Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
Generated substantial procedure growth in 2023 driven by best-in-class efficacy of balloon program; prioritizing key investments in strategic markets and digital innovations ahead of FDA milestones ...